Coronavirus

North Carolina-based McGeever Family Office is seeking up to $75m for its debut vehicle focused on backing the commercialisation efforts of US medical devices and diagnostics companies.

The Australian SWF's exposure to the asset class had grown in recent months due to its relative outperformance and currency moves, according to acting CIO Sue Brake.

Tom Walker of Rev1 Ventures addresses the question of whether investors should back biotech start-ups that focus on the coronavirus and other potential pandemics. Here's what you should know.

Appetite for biopharma is on the rise as investors want to back scientific advances and the recession-proof sector, and generalist VCs don’t want to miss out on potential outsized returns.

The registry has partnered with a dozen-plus diagnostic companies on a mission to educate the government where the nation's testing shortages lie.

The top 10 most acquisitive PE investors during the pandemic closed on more than 60 transactions, according to data from S&P Market Intelligence.

As more venture firms become accustomed to virtual pitches, they’re emphasizing reference checks and setting up multiple Zoom calls as a way to verify their investments and better get to know the founders.

Boston-based Brio Systems, an employer COVID-19 testing platform, has raised $1.9 million in seed funding.